PHARMA EVIDENCE ApS: Financial statements 2022
CVR: 34586519
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 551,989 and a net result of DKK 197,361 compared with DKK -442,484 the year before. That is an increase of 181.6% compared with the year before. Equity in the 2022 report amounted to DKK 1,048,110. The solvency ratio was 82.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 551,989
- Profit/Loss
- DKK 197,361
- Equity
- DKK 1,048,110
- Total Assets
- DKK 1,267,896
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 552 t. | 197 t. | 1 mio. | 1 |
| 2021 | - | 196 t. | -442 t. | 851 t. | 1 |
| 2020 | - | 1.1 mio. | 643 t. | 1.3 mio. | 1 |
| 2019 | - | 749 t. | 221 t. | 650 t. | - |
| 2018 | - | 1.1 mio. | 123 t. | 429 t. | - |
Official annual report
Keep an eye on PHARMA EVIDENCE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMA EVIDENCE ApS has published its annual report for 2021. Gross profit came to DKK 196,010, and the net result was DKK -442,484.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.